Form D · Private Equity Fund
KKR Health Care Strategic Growth Fund II (Ontario) L.P.
New York, NY · CIK 0001832291
Offering snapshot reported Feb 11, 2022 · SEC filing
- Reported sold
- $108M Offering amount: $108M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 21
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 11, 2022 | Amendment | $108,250,000 | No comparison | 21 | SEC filing |
| Dec 17, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund, Other
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $1.2M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-383582
Total commitments to this fund and its parallel vehicles are $4,018,082,000.
Limited Partner Interests
The figure disclosed above reflects estimated amounts expected to be paid to placement agents in respect of the offering of Limited Partnership interests of the Issuer
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| UBS Financial Services, Inc. | 8174 | |
| Morgan Stanley Smith Barney LLC | 149777 | |
| Citi Private Advisory, LLC | 153777 | |
| Citigroup Global Markets Inc. | 7059 | |
| Citibank Canada Investment Funds Limited | None |
Source: Form D, filed Feb 11, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert N/A Antablin | Executive |
| Jason N/A Carss | Director |
| Steven N/A Codispoti | Director |
| Terence N/A Gallagher | Director |
| Hadi N/A Husain | Executive |
| Stephen N/A Jordan | Executive |
| Scott N/A Karnas | Executive |
| Philip N/A Kim | Executive |
| N/A N/A Kkr Associates Hcsg Ii Sc Sp | Promoter |
| N/A N/A Kkr Hcsg Ii S.A R.L. | Promoter |
| Joan N/A Lacagnina | Executive |
| Stefan N/A Lambert | Director |
| Christopher N/A Lee | Executive |
| Max N/A Lin | Executive |
| Michael N/A Longo | Executive |
| Jennifer N/A Mc Groarty | Executive |
| Adam N/A Nowak | Executive |
| Ali N/A Satvat | Executive |
| Mary N/A Shaw | Executive |
| Edward N/A Valentino | Executive |
| Thomas N/A Weber | Director |
| Alisa N/A Wood | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
C/O Kohlberg Kravis Roberts & Co. L.P. 30 Hudson Yards, Suite 7500
New York, NY, 10001
New York, NY, 10001